Search
Quest Diagnostics Inc
DGXAdd to Watchlist
195.000USD
-2.745-1.39%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
21.64BMarket Cap
21.17P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Quest Diagnostics Inc is 7.50, ranking 41 out of 76 in the Healthcare Providers & Services industry. The average price target is 198.00, with a high of 215.00 and a low of 169.18.
Analyst Rating
Based on
20
analysts
Buy
Current Rating
221.889
Target Price
+12.20%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
68
Total
8
Median
9
Average
Company name
Ratings
Analysts
Quest Diagnostics Inc
DGX
20
CVS Health Corp
CVS
29
Teladoc Health Inc
TDOC
27
HCA Healthcare Inc
HCA
26
Tenet Healthcare Corp
THC
23
Natera Inc
NTRA
21
1
2
3
...
14
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Quest Diagnostics Inc's expected revenue for the next quarter?
Quest Diagnostics Inc's expected revenue is 2.97B.
What is Quest Diagnostics Inc's price target?
Analysts forecast that Quest Diagnostics Inc's price target is USD 198.00, with the highest forecast at USD 215.00 and the lowest forecast at USD 169.18.
How have Quest Diagnostics IncDGX's recent earnings per share performed?
The market expectation was USD 2.28, while Quest Diagnostics IncDGX's earnings per share (EPS) for the previous quarter was USD 8.90. EPS for the next quarter is expected at USD 2.83.
What is the analyst rating for Quest Diagnostics Inc?
Based on the ratings of Quest Diagnostics Inc's stock from 20 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
